Dermira, an SJE Group investment based in the USA, has elected Ms Halley E. Gilbert to its Board of Directors.
Halley currently serves as senior vice president, corporate development and chief administrative officer of Ironwood Pharmaceuticals overseeing corporate and business development, legal, compliance and government affairs. She has more than two decades of experience guiding biopharmaceutical companies through transformational change, as well as expertise in corporate transactions, governance and the operational and strategic issues relevant to launching new medicines. Prior to joining Ironwood, Halley was vice president, deputy general counsel at Cubist Pharmaceuticals, where she supported the launch of Cubist’s first acute care antibiotic, and prior to Cubist, she served as corporate counsel at Genzyme Corp. She began her career at Skadden, Arps, Slate, Meagher & Flom, where she specialized in mergers and acquisitions and securities law.
The SJE Group congratulates Halley E. Gilbert, Tom Wiggans (Chairman and CEO of Dermira) and the rest of the Board.